Cargando…

Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment

Renal cell carcinoma (RCC) represents about 2–3% of all cancers with over 400,000 new cases per year. Sunitinib, a vascular endothelial growth factor tyrosine kinase receptor inhibitor, has been used mainly for first-line treatment of metastatic clear-cell RCC with good or intermediate prognosis. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouchalova, Pavla, Beranek, Jindrich, Lapcik, Petr, Potesil, David, Podhorec, Jan, Poprach, Alexandr, Bouchal, Pavel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467952/ https://www.ncbi.nlm.nih.gov/pubmed/34572331 http://dx.doi.org/10.3390/biomedicines9091145

Ejemplares similares

Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide
por: Lapcik, Petr, et al.
Publicado: (2023)

Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer
por: Janacova, Lucia, et al.
Publicado: (2023)

Current methods for studying metastatic potential of tumor cells
por: Bouchalova, Pavla, et al.
Publicado: (2022)

Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells
por: Bouchalova, Pavla, et al.
Publicado: (2021)

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
por: Fiala, Ondrej, et al.
Publicado: (2020)

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015)

Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
por: Fiala, Ondřej, et al.
Publicado: (2021)

How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?
por: Lapcik, Petr, et al.
Publicado: (2020)

Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients
por: Fiala, Ondrej, et al.
Publicado: (2019)

Evolution and function of calponin and transgelin
por: Hsieh, Tzu-Bou, et al.
Publicado: (2023)

Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
por: Woziwodzka, Karolina, et al.
Publicado: (2021)

Transgelin Up-Regulation in Obstructive Nephropathy
por: Karagianni, Fani, et al.
Publicado: (2013)

The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
por: Fiala, Ondrej, et al.
Publicado: (2018)

Differential Expression of Drosophila Transgelins Throughout Development
por: Vakaloglou, Katerina M., et al.
Publicado: (2021)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
por: Iyer, Ridhima, et al.
Publicado: (2017)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Understanding Nutrition and Metabolism of Threatened, Data-Poor Rheophilic Fishes in Context of Riverine Stocking Success- Barbel as a Model for Major European Drainages?
por: Roy, Koushik, et al.
Publicado: (2021)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
por: Hutson, T E, et al.
Publicado: (2014)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
por: Yildiz, Ibrahim, et al.
Publicado: (2014)

Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2016)

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018)

Erythema multiforme major induced by sunitinib for metastatic renal cell carcinoma
por: Watanabe, Daisuke, et al.
Publicado: (2019)

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
por: Lakomy, Radek, et al.
Publicado: (2017)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
por: Ordu, Çetin, et al.
Publicado: (2016)

Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility
por: Zhou, Hui-min, et al.
Publicado: (2016)

Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
por: Fedorko, Michal, et al.
Publicado: (2017)

Expression of Cofilin-1 and Transgelin in Esophageal Squamous Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2015)

Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma
por: Sun, Yan, et al.
Publicado: (2017)

Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer
por: Liu, Jingwen, et al.
Publicado: (2020)

Transgelin interacts with PARP1 in human colon cancer cells
por: Lew, Zhen-xian, et al.
Publicado: (2020)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
por: Billemont, B, et al.
Publicado: (2008)

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
por: Molina, Ana M., et al.
Publicado: (2010)

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
por: Chara, Luis, et al.
Publicado: (2011)

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
por: Morizane, Shuichi, et al.
Publicado: (2012)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer
por: Vasileiadis, Theofanis, et al.
Publicado: (2019)

Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma
por: Blagoev, Krastan B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i3vjl9ug8v92p173adqp4gvfm7